av/aurobindo--big.svg

NSE:AUROPHARMA

Aurobindo Pharma Limited

  • Stock

INR

Last Close

1,084.05

25/04 07:00

Market Cap

680.19B

Beta: 0.48

Volume Today

721.21K

Avg: 2.09M

PE Ratio

25.84

PFCF: −10,376.22

Dividend Yield

0.59%

Payout:0%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
revenue
80.39B
-
120.43B
49.81%
136.49B
13.34%
146.64B
7.43%
161.99B
10.47%
192.26B
18.68%
227.38B
18.27%
245.58B
8.00%
233.67B
4.85%
246.17B
5.35%
cost of revenue
36.06B
-
55.06B
52.68%
61.58B
11.84%
64.34B
4.49%
67.53B
4.95%
87.13B
29.02%
97.35B
11.74%
99.02B
1.72%
101.40B
2.40%
112.93B
11.37%
gross profit
44.33B
-
65.37B
47.49%
74.92B
14.60%
82.30B
9.85%
94.46B
14.79%
105.13B
11.29%
130.03B
23.68%
146.55B
12.71%
132.26B
9.75%
133.24B
0.74%
selling and marketing expenses
3.99B
-
9.34B
134.02%
9.47B
1.31%
11.30B
19.43%
10.90B
3.56%
11.92B
9.36%
15.95B
33.83%
16.43B
3.00%
15.69B
4.55%
16.86B
7.47%
general and administrative expenses
989.40M
-
2.65B
167.38%
2.65B
0.07%
3.31B
25.19%
4.10B
23.61%
4.25B
3.69%
6.52B
53.39%
8.27B
26.94%
6.45B
22.03%
6.62B
2.72%
selling general and administrative expenses
4.98B
-
11.99B
140.65%
12.11B
1.04%
14.62B
20.69%
15.00B
2.60%
16.17B
7.81%
22.47B
38.97%
24.70B
9.94%
22.13B
10.40%
23.48B
6.09%
research and development expenses
50.90M
-
253M
397.05%
150.60M
40.47%
165.80M
10.09%
292.20M
76.24%
756.30M
158.83%
1.22B
61.03%
688.10M
43.50%
652.40M
5.19%
395.10M
39.44%
other expenses
189.90M
-
431.50M
127.22%
299.50M
30.59%
306.10M
2.20%
803.70M
162.56%
1.02B
26.76%
652.90M
35.91%
2.26B
245.81%
1.35B
40.40%
2.91B
115.96%
cost and expenses
61.62B
-
97.17B
57.68%
107.85B
11.00%
116.22B
7.76%
129.32B
11.27%
159.17B
23.09%
187.96B
18.09%
200.82B
6.84%
200.69B
0.06%
221.03B
10.14%
operating expenses
25.56B
-
42.11B
64.73%
46.28B
9.89%
51.88B
12.10%
61.79B
19.11%
72.05B
16.60%
90.61B
25.76%
101.79B
12.34%
99.28B
2.46%
108.10B
8.88%
interest expense
937.90M
-
708.60M
24.45%
793.30M
11.95%
545.10M
31.29%
628.90M
15.37%
1.51B
139.75%
1.42B
6.07%
595.70M
57.94%
368.40M
38.16%
1.40B
281.32%
ebitda
19.94B
-
26.44B
32.61%
32.18B
21.68%
35.71B
10.99%
38.89B
8.90%
40.23B
3.43%
49.21B
22.35%
53.78B
9.28%
46.21B
14.08%
39.98B
13.49%
operating income
18.76B
-
23.26B
23.99%
28.64B
23.13%
30.42B
6.21%
32.67B
7.41%
33.08B
1.26%
39.40B
19.09%
44.54B
13.03%
33.06B
25.76%
25.51B
22.83%
depreciation and amortization
3.13B
-
3.33B
6.42%
3.93B
18.04%
4.28B
8.92%
5.58B
30.48%
6.68B
19.71%
9.67B
44.73%
10.55B
9.17%
11.27B
6.74%
12.45B
10.48%
total other income expenses net
-3.44B
-
-1.58B
53.92%
-1.42B
10.48%
187.20M
113.21%
-262.40M
240.17%
-2.17B
727.36%
-1.97B
9.24%
28.90B
1,566.64%
663.10M
97.71%
610.30M
7.96%
income before tax
15.33B
-
21.68B
41.46%
27.22B
25.58%
30.61B
12.43%
32.41B
5.89%
30.91B
4.62%
37.43B
21.08%
73.44B
96.19%
33.73B
54.07%
26.13B
22.54%
income tax expense
3.63B
-
5.97B
64.15%
7.44B
24.77%
7.60B
2.05%
8.18B
7.72%
7.27B
11.17%
9.14B
25.68%
20.10B
120.00%
7.26B
63.89%
6.85B
5.62%
net income
11.73B
-
15.76B
34.35%
19.82B
25.78%
23.02B
16.13%
24.23B
5.28%
23.65B
2.41%
28.45B
20.32%
53.35B
87.51%
26.48B
50.36%
19.27B
27.21%
weighted average shs out
582.49M
-
583.52M
0.18%
584.16M
0.11%
585.21M
0.18%
585.88M
0.11%
585.91M
0.00%
585.94M
0.01%
585.94M
0%
585.94M
0%
585.94M
0%
weighted average shs out dil
583.16M
-
583.77M
0.10%
584.32M
0.09%
585.22M
0.15%
585.89M
0.11%
585.94M
0.01%
585.94M
0.00%
585.94M
0%
585.94M
0%
585.94M
0%
eps
20.14
-
27.03
34.21%
34.67
28.26%
39.33
13.44%
41.36
5.16%
40.36
2.42%
48.56
20.32%
91.05
87.50%
45.20
50.36%
32.90
27.21%
epsdiluted
20.11
-
27
34.26%
34.66
28.37%
39.33
13.47%
41.36
5.16%
40.36
2.42%
48.56
20.32%
91.05
87.50%
45.20
50.36%
32.90
27.21%

All numbers in INR (except ratios and percentages)

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.